Physician profile
Patrick Kimbrell
NPI 1659471100
$969.88
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30.24 · 2021: $156 · 2022: $47.66 · 2023: $408 · 2024: $328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $736.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $736.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $417.16 | 2021-2024 | Puraply, Puraply Antimicrobial |
| Convatec INC. | $220.28 | 2023-2024 | |
| Medtronic, INC. | $148.60 | 2024 | Intellis Adaptivestim |
| Abbvie INC. | $63.15 | 2021-2024 | |
| Kerecis Limited | $30.24 | 2019 | |
| Next Science LLC | $24.90 | 2023 | Surgx, Blastx, Xperience |
| Smith+Nephew, INC. | $23.05 | 2024 | Collagenase Santyl |
| Deroyal Industries, INC. | $14.68 | 2022 | |
| Hydrofera LLC | $14.60 | 2023 | Hydrofera Blue |
| Integra Lifesciences Corporation | $13.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Kimbrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.